Skip to main content
OpenTrials
Completed

NCT Number: NCT04602312

How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample)

Both mindfulness meditation and expectancy effects are known to reduce anxiety, stress and catastrophizing, but it is unknown whether and how expectancy effects contribute to the overall effect of mindfulness meditation on these outcomes, especially during significant global events such as the coronavirus pandemic. This study includes four interrelated aims that will probe these effects and interactions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Catastrophizing Coronavirus (COVID-19) COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Health and Behavioural Sciences

Brisbane, Queensland, 4072, Australia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • Able to read and understand English

Exclusion criteria

  • Recurrent pain (two or more days in the last month)
  • Chronic pain (pain most days in the last three months)
  • Incomplete or invalid data (response time < 32 minutes, failing attention checks)
  • Completing the 20-minute training module in < 18 minutes or > 90 minutes

Treatment and study plan

Meditation (1 x 20-minute guided audio training)

Other

Participants will complete a single session of 20-minutes online guided audio-delivered training session of one of the four conditions.

Primary outcomes

  1. Coronavirus-related catastrophizing

    Time frame: 40 minutes

    assessed via a covid-19-related catastrophizing scale (CCS; 0=no catastrophizing, 52=highest catastrophizing, 30+=clinically significant catastrophizing)

Other outcomes

  1. Expectancy

    Time frame: 40 minutes

    assessed via self-report questions (0=lowest expectancy, 10=highest expectancy)

  2. Reappraisal

    Time frame: 40 minutes

    assessed via the Cognitive Emotion Regulation Questionnaire (CERQ-R; 4=lowest reappraisal, 20=highest reappraisal)

  3. Mindful observing

    Time frame: 40 minutes

    assessed via the Five Facet Mindfulness Questionnaire Observing subscale (FFMQ-O; 1=lowest observing, 5=highest observing)

  4. Mindful non-reactivity

    Time frame: 40 minutes

    assessed via the Five Facet Mindfulness Questionnaire Non-reacting subscale (FFMQ-NR; 1=lowest non-reactivity, 5=highest non-reactivity)

  5. State Mindfulness

    Time frame: 40 minutes

    assessed via the State Mindfulness Survey (SMS; 1=lowest mindfulness, 21=highest mindfulness)

  6. State Decentering

    Time frame: 40 minutes

    assessed via the Metacognitive Processes of Decentering - State (MpoD-s; 0=lowest decentering, 3=highest decentering)

Sponsors and collaborators

Lead sponsor

The University of Queensland

Other

Collaborators

  • University of California, San Diego
  • University of Sydney

Registry information

Official study title

Online RCT Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Coronavirus-related Catastrophizing in Adults

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Oct 26, 2020
Registry last updated
Jan 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.